Invesco China Health Care Equity Fd.C H
LU2243645046
Invesco China Health Care Equity Fd.C H/ LU2243645046 /
Стоимость чистых активов31.05.2024 |
Изменение0.0000 |
Тип доходности |
Инвестиционная направленность |
Инвестиционная компания |
4.6700SGD |
0.00% |
reinvestment |
Equity
Sector Health / Pharma
|
Invesco Management ▶ |
Инвестиционная стратегия
The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
Инвестиционная цель
The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
Основные данные
Тип доходности: |
reinvestment |
Категории фондов: |
Equity |
Страна: |
China |
Branch: |
Sector Health / Pharma |
Бенчмарк: |
MSCI China A Onshore Health Care Index |
Начало рабочего (бизнес) года: |
29.02 |
Last Distribution: |
- |
Депозитарный банк: |
- |
Место жительства фонда: |
Luxembourg |
Разрешение на распространение: |
Austria, Germany, Switzerland |
Управляющий фондом: |
Chris Liu, Kehong Jiang |
Объем фонда: |
486.11 млн
EUR
|
Дата запуска: |
15.12.2020 |
Инвестиционная направленность: |
- |
Условия
Эмиссионная надбавка: |
5.00% |
Max. Administration Fee: |
1.00% |
Минимальное вложение: |
1,200,000.00 SGD |
Deposit fees: |
0.01% |
Комиссионные, взимаемые фондами взаимных инвестиций при погашении акций: |
0.00% |
Упрощенный проспект: |
Скачать (Версия для печати) |
Инвестиционная компания
Товарищества на вере: |
Invesco Management |
Адрес: |
An der Welle 5, 60322, Frankfurt am Main |
Страна: |
Germany |
Интернет: |
www.de.invesco.com
|
Страны
China |
|
65.14% |
Cash |
|
3.09% |
Cayman Islands |
|
3.05% |
Другие |
|
28.72% |
Отрасли
Pharma/Biotechnology |
|
50.29% |
Healthcare appliances |
|
14.53% |
Healthcare services |
|
3.36% |
Cash |
|
3.09% |
Другие |
|
28.73% |